Evidence map›Paper›PMID 27903826›Full record

ReviewEssays in biochemistry2016

Synthetic biology approaches to biological containment: pre-emptively tackling potential risks.

Leticia Torres, Antje Krüger, Eszter Csibra, Edoardo Gianni, Vitor B Pinheiro

Abstract readReview
In one paragraph

Review in Essays in biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leticia TorresDepartment of Structural and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, U.K. leticia.torres@ucl.ac.uk v.pinheiro@ucl.ac.uk.
Antje KrügerDepartment of Structural and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, U.K.
Eszter CsibraDepartment of Structural and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, U.K.
Edoardo GianniDepartment of Structural and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, U.K.
Vitor B PinheiroDepartment of Structural and Molecular Biology, University College London, Gower Street, London, WC1E 6BT, U.K. leticia.torres@ucl.ac.uk v.pinheiro@ucl.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/K018132/1
6 · The paper itself

Abstract

Biocontainment comprises any strategy applied to ensure that harmful organisms are confined to controlled laboratory conditions and not allowed to escape into the environment. Genetically engineered microorganisms (GEMs), regardless of the nature of the modification and how it was established, have potential human or ecological impact if accidentally leaked or voluntarily released into a natural setting. Although all evidence to date is that GEMs are unable to compete in the environment, the power of synthetic biology to rewrite life requires a pre-emptive strategy to tackle possible unknown risks. Physical containment barriers have proven effective but a number of strategies have been developed to further strengthen biocontainment. Research on complex genetic circuits, lethal genes, alternative nucleic acids, genome recoding and synthetic auxotrophies aim to design more effective routes towards biocontainment. Here, we describe recent advances in synthetic biology that contribute to the ongoing efforts to develop new and improved genetic, semantic, metabolic and mechanistic plans for the containment of GEMs.

Indexed as

Containment of BiohazardsGenetic EngineeringGenomePlasmidsRiskSynthetic Biology

Identifiers

PMID27903826
PMCPMC5264511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.